DOCUMENT
supplementary figure a.docx (63.08 kB)
DOCUMENT
supplementary figure b.docx (62.21 kB)
DOCUMENT
supplementary figure c.docx (61.74 kB)
DOCUMENT
supplementary figure d.docx (63.16 kB)
DOCUMENT
supplementary figure e.docx (96.43 kB)
DOCUMENT
supplementary figure f.docx (94.74 kB)
DOCUMENT
supplementary figure g.docx (99.48 kB)
DOCUMENT
supplementary table a.docx (19.88 kB)
DOCUMENT
supplementary table b.docx (20.06 kB)
1/0
Supplementary materials: Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver
dataset
posted on 2024-05-03, 08:13 authored by Firas Baidoun, Zahi Merjaneh, Rama Nanah, Anas Saad, Omar Abdel-RahmanThese are peer-reviewed supplementary materials for the article 'Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver' published in the Journal of Comparative Effectiveness Research.
- Supplementary figure A: Median overall survival in the whole cohort according to the treatment modality after propensity score matching.
- Supplementary figure B: Overall survival according to the treatment modality after excluding patients with 90-day mortality of most definitive primary site surgery after propensity score matching.
- Supplementary figure C: Median overall survival comparison between single agent and multiagent chemotherapy after propensity score matching.
- Supplementary figure D: Median overall survival comparison between adjuvant and neoadjuvant chemotherapy after propensity score matching.
- Supplementary figure E: Median overall survival according to the treatment modality in (A) MSI-H and (B) MSI-L.
- Supplementary figure F: Median overall survival comparison between single agent and multiagent chemotherapy in (A) MSI-H and (B) MSI-L.
- Supplementary figure G: Median overall survival comparison between adjuvant and neoadjuvant chemotherapy in (A) MSI-H and (B) MSI-L.
- Supplementary Table A: Baseline characteristics of metastatic CRC patients with liver metastases according to the treatment modality after propensity score matching.
- Supplementary Table B: Baseline characteristics of metastatic CRC patients with liver metastases excluding patients with 90-day mortality of most definitive primary site surgery according to the treatment modality after propensity score matching.
